JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB280101

Human PARK2 (Parkin) knockout SH-SY5Y cell lysate

Be the first to review this product! Submit a review

|

(1 Publication)

PRKN KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 77 bp Deletion in Exon 5.
2 Images
Western blot - Human PARK2 (Parkin) knockout SH-SY5Y cell lysate (AB280101)
  • WB

Lab

Western blot - Human PARK2 (Parkin) knockout SH-SY5Y cell lysate (AB280101)

Lane 1 : Wild-type SH-SY5Y cell lysate 20 μg
Lane 2 : PRKN knockout SH-SY5Y cell lysate 20 μg
Lane 3 : Human Brain tissue lysate 20 μg
Lane 4 : HUVEC cell lysate 20 μg
Lanes 1 - 4 : Merged signal (red and green). Green - ab77924 observed at 49 kDa. Red - loading control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37kDa.
ab77924 was shown to react with Parkin in wild-type SH-SY5Y cells in Western blot with loss of signal observed in PRKN knockout cell line ab280042 (PRKN knockout cell lysate ab280101). Wild-type SH-SY5Y and PRKN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab77924 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4 °C at 5 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-Parkin antibody [PRK8] (<a href='/en-us/products/primary-antibodies/parkin-antibody-prk8-ab77924'>ab77924</a>) at 5 µg/mL

Lane 1:

Wild-type SH-SY5Y cell lysate at 20 µg

Lane 2:

PRKN knockout SH-SY5Y cell lysate at 20 µg

Lane 2:

Western blot - Human PARK2 (Parkin) knockout SH-SY5Y cell line (<a href='/en-us/products/cell-lines/human-park2-parkin-knockout-sh-sy5y-cell-line-ab280042'>ab280042</a>)

Lane 3:

Human Brain tissue lysate at 20 µg

Lane 4:

HUVEC cell lysate at 20 µg

Predicted band size: 52 kDa

Observed band size: 49 kDa

false

Sanger Sequencing - Human PARK2 (Parkin) knockout SH-SY5Y cell lysate (AB280101)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human PARK2 (Parkin) knockout SH-SY5Y cell lysate (AB280101)

Human PRKN KO in SH-SY5Y Cells with 77 bp Deletion in Exon 5

Key facts

Cell type

SH-SY5Y

Species or organism

Human

Tissue

Bone marrow

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 77 bp Deletion in Exon 5

Disease

Neuroblastoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab280101-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PARK2 knockout SHSY-5Y cell lysate", "number":"AB280101-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type SHSY-5Y cell lysate", "number":"AB280101-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PRKN
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-80°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Parkin protein also known as PRK8 or Park2 is an E3 ubiquitin ligase with a molecular weight of approximately 52 kDa. This protein plays a critical role in tagging damaged proteins for degradation maintaining cellular health. Parkin is expressed in various tissues with significant levels in dopaminergic neurons in the brain. It is encoded by the PARK2 gene and has been linked to the regulation of mitochondrial quality and autophagy processes contributing to cellular homeostasis.
Biological function summary

Parkin is essential for the regulation of mitochondria through its involvement in the mitochondrial quality control system. It functions as part of a complex with other proteins that respond to mitochondrial damage by tagging them with ubiquitin molecules. This mechanism allows for the removal of defective mitochondria via mitophagy critical for preventing the accumulation of damaged cellular components.

Pathways

Parkin interacts with pathways involved in the cellular stress response particularly the PINK1 (PTEN Induced Kinase

  1. pathway. PINK1 phosphorylates Parkin activating it to label damaged mitochondria. Another critical pathway involves proteasomal degradation where Parkin collaborates with Ubiquitin to manage protein turnover. These pathways highlight its relationships with other cellular stress-regulating proteins enhancing our understanding of its roles in maintaining cellular integrity.
Mutations in the gene coding for Parkin are linked to Parkinson's disease (PD) and some forms of juvenile autosomal recessive parkinsonism. The Parkin protein's dysfunctional activity leads to impaired mitochondrial management and protein aggregation in neurons contributing significantly to neurodegenerative disease. In conditions such as PD Parkin interacts with other proteins such as PINK1 reinforcing its role in mitochondrial protection and indicating the protein's importance in disease progression and potential therapeutic targeting.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

SLAS discovery : advancing life sciences R & D 28:73-87 PubMed36608804

2023

High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Roberta Tufi,Emily H Clark,Tamaki Hoshikawa,Christiana Tsagkaraki,Jack Stanley,Kunitoshi Takeda,James M Staddon,Thomas Briston
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com